美国食品药品监督管理局授予Palvella Therapeutics孤儿产品资助第二年资金,用于支持该公司Qtorin™雷帕霉素治疗微囊性淋巴管畸形的三期Selva临床试验。
美国食品药品监督管理局授予Palvella Therapeutics孤儿产品资助第二年资金,用于支持该公司Qtorin™雷帕霉素治疗微囊性淋巴管畸形的三期Selva临床试验。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.